Consun Pharmaceutical (01681) Announces Share Repurchase Details with Issued Shares Unchanged

Bulletin Express12-03

Consun Pharmaceutical Group Limited (Stock Code: 01681) released a disclosure return dated 03 December 2025, indicating that the total number of issued ordinary shares remained at 847,993,407 shares as of 02 December 2025 and continued to be at 847,993,407 shares as of the closing balance on 03 December 2025.

The document shows multiple share repurchases for cancellation conducted between mid-October and early December 2025, totaling 12,078,000 shares acquired under an authorized mandate of 85,126,334 shares. In particular, on 03 December 2025, 290,000 shares were repurchased at prices ranging from HKD 14.66 to HKD 14.74, with an aggregate amount of approximately HKD 4.27 million. Despite these repurchases, the overall issued share capital remained the same as they had not yet been canceled by the closing balance date. The moratorium period for any new share issuance after these repurchases is expected to last until 02 January 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1190577816?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-03 18:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190577816","market":"hk","top_or_hot":-1,"title":"Consun Pharmaceutical (01681) Announces Share Repurchase Details with Issued Shares Unchanged","media":"Bulletin Express","content":"<p>Consun Pharmaceutical Group Limited (Stock Code: 01681) released a disclosure return dated 03 December 2025, indicating that the total number of issued ordinary shares remained at 847,993,407 shares as of 02 December 2025 and continued to be at 847,993,407 shares as of the closing balance on 03 December 2025.</p>\n<p>The document shows multiple share repurchases for cancellation conducted between mid-October and early December 2025, totaling 12,078,000 shares acquired under an authorized mandate of 85,126,334 shares. In particular, on 03 December 2025, 290,000 shares were repurchased at prices ranging from HKD 14.66 to HKD 14.74, with an aggregate amount of approximately HKD 4.27 million. Despite these repurchases, the overall issued share capital remained the same as they had not yet been canceled by the closing balance date. The moratorium period for any new share issuance after these repurchases is expected to last until 02 January 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consun Pharmaceutical (01681) Announces Share Repurchase Details with Issued Shares Unchanged</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsun Pharmaceutical (01681) Announces Share Repurchase Details with Issued Shares Unchanged\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-03 18:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Consun Pharmaceutical Group Limited (Stock Code: 01681) released a disclosure return dated 03 December 2025, indicating that the total number of issued ordinary shares remained at 847,993,407 shares as of 02 December 2025 and continued to be at 847,993,407 shares as of the closing balance on 03 December 2025.</p>\n<p>The document shows multiple share repurchases for cancellation conducted between mid-October and early December 2025, totaling 12,078,000 shares acquired under an authorized mandate of 85,126,334 shares. In particular, on 03 December 2025, 290,000 shares were repurchased at prices ranging from HKD 14.66 to HKD 14.74, with an aggregate amount of approximately HKD 4.27 million. Despite these repurchases, the overall issued share capital remained the same as they had not yet been canceled by the closing balance date. The moratorium period for any new share issuance after these repurchases is expected to last until 02 January 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01681","symbol_name":"康臣药业","start_time":0,"source_url":"","article_id":"1190577816","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190577816","pubTimestamp":1764756425,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Consun Pharmaceutical Group Limited (Stock Code: 01681) released a disclosure return dated 03 December 2025, indicating that the total number of issued ordinary shares remained at 847,993,407 shares...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01681":"康臣药业"},"translate_title":"康臣药业(01681)公布已发行股份不变的股份购回详情","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"Consun Pharmaceutical Group Limited (Stock Code: 01681) released a disclosure return dated 03 December 2025, indicating that the total number of issued ordinary shares remained at 847,993,407 shares as of 02 December 2025 and continued to be at 847,993,407 shares as of the closing balance on 03 December 2025.\nThe document shows multiple share repurchases for cancellation conducted between mid-October and early December 2025, totaling 12,078,000 shares acquired under an authorized mandate of 85,126,334 shares. In particular, on 03 December 2025, 290,000 shares were repurchased at prices ranging from HKD 14.66 to HKD 14.74, with an aggregate amount of approximately HKD 4.27 million. Despite these repurchases, the overall issued share capital remained the same as they had not yet been canceled by the closing balance date. The moratorium period for any new share issuance after these repurchases is expected to last until 02 January 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1190577816","isCrawlerRequest":true}